Cargando…
Antipsychotic-Related Stigma and the Impact on Treatment Choices: A Systematic Review and Framework Synthesis
BACKGROUND: Antipsychotics are a class of medications primarily used to treat individuals with psychotic disorders. They have also been indicated for patients with other psychiatric conditions, such as post-traumatic stress disorder and major depressive disorder. Non-adherence is prominent amongst i...
Autores principales: | Townsend, Michael, Pareja, Kristin, Buchanan-Hughes, Amy, Worthington, Emma, Pritchett, David, Brubaker, Malaak, Houle, Christy, Mose, Tenna Natascha, Waters, Heidi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859276/ https://www.ncbi.nlm.nih.gov/pubmed/35210756 http://dx.doi.org/10.2147/PPA.S343211 |
Ejemplares similares
-
Life Engagement Improvement Following Initiation of Brexpiprazole Treatment in Patients with MDD: A Naturalistic, Retrospective Real-World Study
por: Wee, Soon Nan, et al.
Publicado: (2023) -
Impact of Atypical Antipsychotics as Adjunctive Therapy on Psychiatric Cost and Utilization in Patients with Major Depressive Disorder
por: Yan, Tingjian, et al.
Publicado: (2020) -
Antipsychotic prescribing choices in patients with First Episode Psychosis
por: Fallon, J., et al.
Publicado: (2022) -
A public health framework for reducing stigma: the example of weight stigma
por: Harwood, Alison, et al.
Publicado: (2022) -
Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment
por: Muric, Nemanja N., et al.
Publicado: (2020)